The STAT transcription factors are involved in the development of many forms of cancer. STAT3 is frequently activated in tumor cells, so drugs targeting STAT3 could be used in cancer therapy. However, STAT3 is also important in the development of the immune system. Researchers now show that blocking STAT3 in cells of the immune system actually leads to increased anti-tumor immunity. Anti-STAT3 therapy may thus be highly promising.